Advertisement

Prostaglandin production and stimulation by angiotensin II in the isolated perfused human placental cotyledon

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Levels of prostaglandins E and F, thromboxane B2, and 6-oxo-prostaglandin F were measured by radioimmunoassay in the maternal and fetal effluents of isolated human placental cotyledons perfused in vitro. All prostaglandins measured were released in greater amounts by the maternal side than by the fetal side of the perfused cotyledon although there were no consistent concentration gradients between the two sides. The approximate rank order of prostaglandin release into the maternal side was thromboxane B2 > prostaglandin F ⋍ prostaglandin E ⋍- 6-oxo-prostaglandin F, and that into the fetal side was thromboxane B2 ⋍ prostaglandin F ⋍ prostaglandin E ⋍ 6-oxo-prostaglandin F. Injection of angiotensin II (0.5 μg) into the fetal circulation stimulated prostaglandin E and 6-oxo-prostaglandin F but not thromboxane B2 and prostaglandin F release into the fetal circulation and had no effect on maternal release. Angiotensin II (0.5 μg) had no effect on either side of the perfused cotyledon when injected into the maternal circulation. It is proposed that prostaglandin release into both maternal and fetal circulations may be flow-dependent and that the angiotensin II-stimulated release of prostaglandin E and 6-oxo-prostaglandin F may serve to modulate the vasoactive actions of angiotensin II on the fetal vasculature.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rankin JHG
        • McLaughlin MK
        The regulation of the placental blood flow.
        J Dev Physiol. 1979; 1: 3
        • Goodman RP
        • Killam AP
        • Brash AR
        • Branch RA
        Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension.
        Am J Obstet Gynecol. 1982; 142: 817
        • Tulenko TN
        The actions of prostaglandins and cyclo-oxygenase inhibition on the resistance vessels supplying the human fetal placenta.
        Prostaglandins. 1981; 21: 1033
        • Misiani R
        • Remuzzi G
        • Mecca G
        Prostacyclin generation by human umbilical and placental vessels in normal and hypertensive pregnancy.
        in: Lewis PJ O'Grady J Clinical pharmacology of prostacyclin. Raven Press, New York1981
        • Rudolph AM
        The effects of nonsteroidal anti-inflammatory compuunds on fetal circulation and pulmonary function.
        Obstet Gynecol. 1981; 58: 635
        • Ferris JF
        • Weir EK
        Effect of captopril on uterine blood flow and prostaglandin E synthesis in the pregnant rabbit.
        J Clin Invest. 1983; 71: 809
        • Symonds EM
        • Broughton-Pipkin F
        Pregnancy hypertension, parity, and the renin-angiotensin system.
        Am J Obstet Gynecol. 1978; 132: 473
        • Terragno NA
        • Terragno DA
        • Pacholczyk D
        • McGiff JC
        Prostaglandins and the regulation of uterine blood flow in pregnancy.
        Nature. 1974; 249: 57
        • Glance DG
        • Elder MG
        • Bloxam DL
        • Myatt L
        The effects of components of the renin-angiotensin system on the isolated perfused human placental cotyledon.
        Am J Obstet Gynecol. 1984; 149: 450
        • Myatt L
        • Bray MA
        • Gordon D
        • Morley J
        Macrophages on intrauterine contraceptive devices produce prostaglandins.
        Nature. 1975; 257: 227
        • Hensby CN
        • Jogee M
        • Elder MG
        • Myatt L
        A comparison of the quantitative analysis of 6-oxo-PGF in biological fluids by gas chromatography, mass spectrometry and radioimmunoassay.
        Biomed Mass Spectrom. 1981; 8: 111
        • Kunzel W
        Umbilical circulation—physiology and pathology.
        J Perinat Med. 1981; 9: 68
        • Mitchell MD
        Prostaglandins during pregnancy and the perinatal period.
        J Reprod Fertil. 1981; 62: 305
        • Dembele-Duchesne MJ
        • Thaler-Dao H
        • Chavris C
        • Crastes de Paulet A
        Some new prospects in the mechanism of control of arachidonate metabolism in human placenta and amnion.
        Prostaglandins. 1981; 22: 979
        • Aiken JW
        • Vane JR
        Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin.
        J Pharmacol Exp Ther. 1973; 184: 678
        • Piper PJ
        • Vane JR
        The release of prostaglandin from lung and other tissues.
        Ann NY Acad Sci. 1971; 180: 363
        • Omini C
        • Vigani T
        • Marini A
        • Pasargiklian R
        • Fano M
        • Maselli MA
        Angiotensin II: a releaser of PGI2 from fetal and newborn rabbit lungs.
        Prostaglandins. 1983; 25: 901